CompletedPhase 2NCT00190918
A Trial for Patients With Gestational Trophoblastic Disease
Studying Gestational choriocarcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eli Lilly and Company
- Principal Investigator
- David Miller, MDGynecologic Oncology Group
- Intervention
- Pemetrexed(drug)
- Enrollment
- 50 enrolled
- Eligibility
- FEMALE
- Timeline
- 2006 – 2007
Study locations (1)
- Gynecologic Oncology Group 215-854-0770, Philadelphia, Pennsylvania, United States
Collaborators
Gynecologic Oncology Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00190918 on ClinicalTrials.govOther trials for Gestational choriocarcinoma
Additional recruiting or active studies for the same condition.